1000s of practice questions to help you prepare for the 2023 GPhC registration assessment, including extended matching answer, single best answer and calculations.
NICE recommends tenecteplase for treating acute ischaemic stroke patients
Tenecteplase was found to be as effective as alteplase, which is more expensive, and the National Institute for Health and...
NSAID prescribing in high-risk groups is a major source of avoidable harm, study finds
The study estimated that the practice could have caused more than 6,000 lost years of good health across England over...
*DEADLINE EXTENDED* Nominate a female pharmacy professional for our Women to Watch 2024 list
Help us find and celebrate brilliant, unrecognised women who are accomplishing great things in pharmacy....
MHRA approves capivasertib for treatment of advanced breast cancer
Capivasertib is an oral pill given with fulvestrant, a hormonal therapy, as an alternative treatment to endocrine-based regimens....
Less is more: the struggle to prioritise structured medication reviews
With primary care networks no longer incentivised to carry out structured medication reviews, work is under way to make sure...
Copyright © 2024 Royal Pharmaceutical Society
Designed and built by Redwing Interactive
